tradingkey.logo

AxoGen Inc

AXGN
查看详细走势图
34.945USD
-0.075-0.21%
交易中 美东报价延迟15分钟
1.61B总市值
亏损市盈率 TTM

AxoGen Inc

34.945
-0.075-0.21%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.21%

5天

+0.65%

1月

+12.73%

6月

+175.81%

今年开始到现在

+6.77%

1年

+91.90%

查看详细走势图

TradingKey AxoGen Inc股票评分

单位: USD 更新时间: 2026-02-02

操作建议

AxoGen Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名3/206位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价36.60。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

AxoGen Inc评分

相关信息

行业排名
3 / 206
全市场排名
44 / 4529
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

AxoGen Inc亮点

亮点风险
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
业绩高增长
公司营业收入稳步增长,连续3年增长35.18%
估值低估
公司最新PE估值-837.40,处于3年历史低位
机构加仓
最新机构持股42.08M股,环比增加0.02%
CI 精选加拿大股票基金持仓
明星投资者CI 精选加拿大股票基金持仓,最新持仓市值2.15K
活跃度增加
近期活跃度增加,过去20天平均换手率2.01

分析师目标

根据 10 位分析师
买入
评级
36.600
目标均价
+5.02%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

AxoGen Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

AxoGen Inc简介

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
公司代码AXGN
公司AxoGen Inc
CEODale (Michael Donald)
网址https://www.axogeninc.com/
KeyAI